Gamma-aminobutyric Acid

γ-氨酪酸

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameGamma-aminobutyric Acid
Drug Alias Name伽玛氨基丁酸γ-Aminobutyric Acidγ-氨基丁酸伽马氨酪酸伽马氨基丁酸 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGamma-aminobutyric acid A receptor agonists
TargetsGamma-aminobutyric acid A receptor
Therapy Area/IndicationsCarbon Monoxide PoisoningHeadacheChronic Pain +[9] 
Global Approved IndicationsCarbon Monoxide PoisoningHeadacheSleep Wake Disorders +[7] 
Approved Indications in ChinaCarbon Monoxide PoisoningStrokeIntracranial Arteriosclerosis
Original Approved Country/TerritoryJapan
Original Approved Date1959/09/22
Country/TerritoryUnited StatesMainland ChinaJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesAlfresa PharmaUniversity Of FloridaUniversity Of Alabama At Birmingham +[4] 
Inactive CompaniesN/A
Active IndicationsCarbon Monoxide PoisoningHeadacheChronic Pain +[9] 
Inactive IndicationsN/A

Other Information

ATC CodeN03AG03
Related LinksWikipediaDrugBankKEGG